Cerulea Clinical Trials

Close Menu
Close Close

Clinical Trials

ONL1204-OAG-001

A Phase 1b Multicenter, Randomized, Single-Masked, Sham-Controlled Study of the Safety and Tolerability of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma

Overview

  • Principal Investigator
Professor Keith Martin

Learn more

View this study on ClinicalTrials.gov

See the ClinicalTrials.gov database listing for more detailed information about this study.

Read More

Related Pages

Clinical Trials

Register your interest in clinical trials

To express interest in taking part in current or future clinical trials at Cerulea, join our online database.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.